PS-B07-3: ANGIOTENSIN I CONVERTING ENZYME INHIBITORY PEPTIDES DERIVED FROM KATSUOBUSHI. (January 2023)

• Record Type: Journal Article
• Authors: Seki, Eiji
• Is Part Of: Journal of hypertension. Volume 41(2023)Supplement 1
• Page Start: e370
• Page End: e371
• Publication Date: 2023-01
• Subjects: Hypertension -- Periodicals; Hypertension -- Periodicals; 616.132005
• DOI: 10.1097/01.hjh.0000916576.37306.f2
• Languages: English
• ISSNs: 1473-5598

Abstract

Abstract : Purpose: Antihypertensive components are typically assessed by screening based on in vitro results; however, since intestinal absorption is closely involved in the antihypertensive mechanism of action, we attempted to analyze the absorption of bonito derived peptides, which have been found to have antihypertensive effects in animal experiments. Methods: The intestinal tracts of rats, 7 week old male SDrats, were excised after performing cervical dislocation. Incisions 5.5 cm were quickly made into the jejunum, one side was ligated and inverted, and after injecting 1 mL reaction solution, the other side was ligated to create an inverted sack. The sack was then quickly placed in 30 mL of the reaction solution, antihypertensive amount: KBP 0.3 mg/per animal and synthetic peptides: each 0.25 mM, and left to react for 30 min at 37°C after which the inverted sack was removed and washed gently with physiological saline before recovering all the internal fluid. Liquid chromatography tandem mass spectrometry LC/MS/MS was used for analysis and the intestinal fluid samples were measured after examining pretreatment and measurement conditions. Results: Pretreatment conditions involved adding 5 μL water, 5 μL IS L-Leu-D-Leu, and 5 μL of 20% sulfosalicylic acid to a 50 μL intestinal fluid sample, stirring the sample, transferring 0.22 μm to a centrifugal filter, performing centrifugation for 3 min at 20000 g and 4°C and then injecting the filtrate into the LC/MS/MS system. LC conditions included a 1.7 μL ACQUITY UPLC BEH C18 column; 2.1, 50 mM, 0%-100% acetonitrile/0.1% TFA linear gradient elution in the mobile phase. Based on the above analysis conditions, the GW, AW, VW, MW, IW, LW, and WL values ng/mL of KBP in the reaction solution were 34.0, 4.64, 7.11, 1.28, 12.7, 4.57, and 0.923, respectively, and 53.2, 3.92, 6.02, 1.10, 8.76, 5.76, and 0.785, respectively. Values for the reaction solution of additive-free peptides serving as a base were estimated at 13.5, 1.09, 2.06, 0.350, 5.54, 1.72, and 0.189, respectively. The calibration curve range was set at 0.200–1000ng/ mL. Conclusion: The intestinal membrane permeability of dried bonito-derived dipeptides, which have an antihypertensive effect in vivo, suggests that dipeptides absorbed from the intestinal membrane may have an antihypertensive effect.